Key Takeaways
- Tuberous breast correction can attract a Medicare rebate because the condition is a developmental abnormality of the breast, which is a different category from cosmetic augmentation.
- The main item is 45060, single-stage correction of a developmental breast abnormality. The schedule fee is $1,521.60 and the benefit is 75% of that, being $1,141.20.
- Where correction is staged, items 45061 and 45062 cover the two stages on both breasts, and items 45071 and 45072 the unilateral equivalents.
- Most of the items are written around measurable thresholds: a volume difference of at least 20% in normally shaped breasts, or 10% in tubular breasts or breasts with abnormally high inframammary folds. Item 45528 expressly excludes hypomastia.
- Photographic or diagnostic imaging evidence documenting the clinical need must be in the patient notes. Without it there is no claim.
- The rebate is not where most of the value sits. An eligible item number is what activates private health fund cover for the hospital and anaesthetic components.
Tuberous breast deformity is one of the few breast shape conditions that may attract a Medicare rebate in Australia, because it is classified as a developmental abnormality of the breast rather than a cosmetic concern.
That classification opens the door. It does not make coverage automatic. The relevant items are written around measurable findings, and eligibility turns on whether those findings are present and documented.
What follows sets out which items apply, what the criteria require, what documentation is needed, and how private health cover interacts with an eligible item. Full detail on the operation itself sits on the tuberous breast correction page, and the understanding tuberous breast deformity guide covers the anatomy, the features and the Grolleau classification.
Why the condition can qualify
The distinction Medicare draws is between surgery performed for appearance and surgery correcting a developmental abnormality, disease or trauma. Purely aesthetic procedures carry no item number.
Tuberous breast deformity sits in the developmental category. The underlying mechanism is a constricting ring of connective tissue at the base of the breast that prevents normal expansion during development, producing the narrow base, constricted lower pole, high inframammary fold and, in many cases, a herniated areola.
The items that follow are the ones written for developmental breast abnormality. What none of them fund is breast augmentation performed because the breasts are small. Item 45528 makes the point explicitly by excluding hypomastia from its reconstructive indications, and the items built around a measured volume difference exclude it in effect, since small but evenly developed breasts do not produce one.
The item numbers that apply
Item 45060: single-stage correction. The main item. It covers correction of a developmental breast abnormality in one operation, where that correction is either bilateral mastopexy for symmetrical tubular breasts, or surgery on both breasts combining one or more implants (which must differ by at least 10% in volume), mastopexy or reduction mammaplasty, where there is a volume difference between the breasts of at least 20% in normally shaped breasts or 10% in tubular breasts or breasts with abnormally high inframammary folds. Photographic or diagnostic imaging evidence of the clinical need must be documented. Schedule fee $1,521.60, benefit $1,141.20.
Items 45061 and 45062: staged correction of both breasts. Where correction is staged, 45061 covers the first stage, surgery on both breasts combining tissue expanders, mastopexy or reduction mammaplasty. Item 45062 covers the second stage, exchanging the expanders for implants that differ by at least 10% in volume, with mastopexy or reduction mammaplasty as required. Both carry the same volume-difference thresholds and the same evidence requirement as 45060. Schedule fees $1,521.60 and $1,101.10, benefits $1,141.20 and $825.85.
Items 45071 and 45072: staged correction of one breast. The unilateral equivalents, introduced on 1 July 2026. Item 45071 covers insertion of a tissue expander in one breast, and 45072 the exchange of that expander for an implant differing by at least 10% in volume. Schedule fees $1,014.40 and $734.05, benefits $760.80 and $550.55.
Item 45528: bilateral augmentation. Augmentation of both breasts where reconstructive surgery is indicated because of developmental malformation of breast tissue, expressly excluding hypomastia, or because of disease or trauma other than trauma from previous elective cosmetic surgery, or amastia secondary to a congenital endocrine disorder. Photographic or diagnostic imaging evidence is required. Schedule fee $1,331.35, benefit $998.55.
Item 45524: unilateral augmentation. Augmentation of one breast in the context of a developmental abnormality, where the volume difference meets the 20% or 10% threshold demonstrated by an appropriate volumetric measurement technique. Schedule fee $887.70, benefit $665.80.
Item 45556: unilateral ptosis correction. Correction of ptosis on one side in the context of a developmental abnormality, supported by photographic or imaging evidence. Payable only where performed unilaterally to match the other breast, and only once per patient. Schedule fee $916.85, benefit $687.65.
Items 45534 and 45535: autologous fat grafting. Fat harvesting, preparation and injection, unilateral and bilateral respectively. The purposes written into both items include the correction of developmental disorders of the breast, with photographic or imaging evidence required and a limit of four services. Schedule fees $756.10 and $1,323.35, benefits $567.10 and $992.55.
Which items apply depends on the surgical plan and on the measurements taken at consultation. Schedule fees are indexed periodically, so check the current figures on MBS Online if you are budgeting closely.
What the criteria require
Reading across the items, three things do the work.
A documented developmental abnormality. Examination findings recording the features: the constricted base, the high inframammary fold, the deficient lower pole, areolar herniation and the degree of asymmetry. The Grolleau type is a useful way of recording severity and it informs the surgical plan, though the items themselves are written around measurement rather than around a classification type.
A measured volume difference. Most of the items specify at least 20% in normally shaped breasts, or 10% in tubular breasts or breasts with abnormally high inframammary folds, demonstrated by an appropriate volumetric measurement technique. Item 45060 also covers bilateral mastopexy for symmetrical tubular breasts, which is the route where both sides are affected evenly and there is no meaningful difference between them.
Photographic or diagnostic imaging evidence. Documented in the patient notes, demonstrating the clinical need for the service. Medicare billing is subject to audit and this is what an audit looks for. Photographs taken at home do not meet this requirement, though they can be useful background at a first consultation.
The assessment is made at consultation against measurements and examination findings. It cannot be judged from images sent in advance, and it does not turn on how strongly a patient feels about the appearance.
Documentation
For a claim under these items the record generally needs:
- A GP referral setting out the history and the reason for referral
- Specialist examination findings covering base width, fold position, lower pole length, areolar features and asymmetry
- Standardised clinical photographs taken at consultation
- Volumetric measurement demonstrating the difference between the breasts, where the applicable item requires it
- The Grolleau type recorded
- A surgical plan identifying the items that apply
The pathway from GP to surgery
Step one. GP consultation, history documented, and a referral. A referral is required before a first surgical consultation regardless of whether Medicare is being pursued.
Step two. First surgical consultation. Examination, measurement, Grolleau classification, standardised photographs, and discussion of the surgical plan and which items may apply.
Step three. Between consultations. Any further investigation, and verification with your health fund that the relevant item numbers are covered at your policy level.
Step four. Second consultation. At least two consultations are required before surgery is booked. Documentation is reviewed, eligibility confirmed or the gaps identified, and the plan finalised. Psychological assessment is part of the current framework.
Step five. Cooling-off period between consent and surgery.
Step six. Surgery at an accredited private hospital.
Where eligibility is being pursued, the pathway commonly runs to several months from first GP visit to surgery. Where correction is staged, the second operation follows months after the first.
How private health cover interacts
Funds contribute where a procedure carries a valid MBS item number and the eligibility criteria are met. That is why the item number matters more than the rebate.
Where an eligible item applies and you hold hospital cover at a level that includes it, with waiting periods served, the fund covers the hospital accommodation and theatre component, and typically contributes to the anaesthetic. Implant cover varies between policies. Gaps generally remain on the surgeon’s and anaesthetist’s fees, and your policy excess applies.
Cover for these items is often limited to higher policy tiers. Verify with your own fund before surgery is booked, quoting the specific item numbers from your surgical plan and your level of cover.
Where no item applies, the procedure is funded privately in full, in the same way as cosmetic augmentation. The breast lift cost guide sets out how an all-inclusive quote is structured.
What Medicare does not cover
- Augmentation for small breasts. Small but normally shaped breasts are not a developmental abnormality, and none of these items apply.
- Cases without documented features. Without examination findings, measurement and photographic or imaging evidence, there is no claim regardless of the clinical picture.
- Revision of previous cosmetic surgery. Where the original procedure was cosmetic, revision is usually treated the same way.
- The full cost of surgery. The benefit is 75% of the schedule fee. Gaps remain on the professional fees.
Item descriptors and schedule fees are reviewed periodically, and the unilateral two-stage items 45071 and 45072 commenced on 1 July 2026. The current descriptor on MBS Online is the authoritative source.
The consultation framework
The cosmetic surgery guidelines that came into force on 1 July 2023 apply to tuberous breast correction even where the procedure attracts a Medicare item. They are separate from, and additional to, eligibility.
A GP referral is required before the first consultation. A minimum of two consultations with the operating surgeon applies before surgery is booked. Psychological assessment is conducted to confirm suitability. A cooling-off period sits between consent and surgery. These apply whichever way the procedure is funded.
Frequently asked questions
Does Medicare always cover tuberous breast correction?
No. Coverage is not automatic. It depends on demonstrating that the presentation meets the criteria written into the relevant items, which means documented developmental features, a measured volume difference meeting the stated threshold where the item requires one, and photographic or diagnostic imaging evidence in the patient notes. Small but normally shaped breasts are hypomastia, which item 45528 expressly excludes and which does not produce the measured volume difference the other items require. Eligibility is assessed at consultation against measurements and examination findings.
How much does Medicare pay toward tuberous correction?
It depends on the items in the surgical plan. The main single-stage item, 45060, has a schedule fee of $1,521.60 and a benefit of $1,141.20. Where correction is staged across both breasts, item 45061 has a benefit of $1,141.20 and item 45062 a benefit of $825.85, with items 45071 and 45072 covering the unilateral equivalents. Other items may apply for bilateral or unilateral augmentation, unilateral ptosis correction or fat grafting. The larger financial effect is not the rebate itself but that an eligible item activates private health fund cover of the hospital and theatre component.
What is the difference between a case that qualifies and one that does not?
Whether the developmental features are present and documented. A breast with a constricted base, a high inframammary fold, a deficient lower pole and areolar herniation, with the volume difference measured where the item requires it, demonstrates a developmental abnormality. A small but normally shaped breast does not, and that is the distinction the items draw. The examination findings, the measurements and the photographic record decide which category a case falls into.
Do I need a GP referral even if I plan to pay privately?
Yes. A referral is required before a first surgical consultation under the current framework, whether or not a Medicare pathway is being pursued. It is part of the consultation requirements rather than a Medicare-specific step, and it applies to the procedure regardless of how it is funded.
How long does the pathway take from GP to surgery?
Commonly several months where eligibility is being pursued. That covers the GP consultation and referral, the first surgical consultation with examination, measurement and photographs, any further investigation, the minimum two consultations required before booking, psychological assessment, the cooling-off period, health fund verification, and scheduling. Where correction is staged, the second operation follows months after the first, so the full course is longer again.
